Naproxen Sodium Tablet, Film Coated, Extended Release
Product Images NDC 0480-0953

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Naproxen Sodium (NDC 0480-0953). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Image 1)

1 (Image 1)
Chemical structure of naproxen sodium showing its molecular formula C14H13NaO3 and molecular weight 252.24.*
FDA Label Image

1 (Image 2)

1 (Image 2)
A pharmacokinetic concentration-time graph depicting plasma levels (mcg/mL) over 24 hours for naproxen 500 mg dosed every 12 hours and naproxen sodium extended-release 1000 mg dosed every 24 hours, including standard deviation bands for both formulations.*
FDA Label Image

1 (Image 3)

1 (Image 3)
Label for Naproxen Sodium Extended-Release Tablets 375 mg by Teva Pharmaceuticals, Inc. The label indicates 100 film-coated extended-release tablets for oral use. It includes NDC 0480-0951-01 and directions to dispense the Medication Guide with each prescription. Storage instructions, manufacturer details, and a barcode are also present.*
FDA Label Image

1 (Image 4)

1 (Image 4)
Label for Naproxen Sodium Extended-Release Tablets, 500 mg strength, film-coated, extended-release oral tablets. The package contains 75 tablets and is labeled for prescription use only. The label includes the NDC number 0480-0952-58 and manufacturer information for Teva Pharmaceuticals, Inc., with details on dosage strength and storage instructions.*
FDA Label Image

1 (Image 5)

1 (Image 5)
Naproxen Sodium Extended-Release Tablets 750 mg film-coated tablets, oral use, in a 30 tablet package from Teva Pharmaceuticals. The label includes dosage information, storage instructions, barcode, and serialization coding area. Manufactured by Watson Pharma Private Limited in India for Teva Pharmaceuticals, Parsippany, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.